Clinical Trials Browser

Completed × Has results × radium Ra 223 dichloride × Clear all

NCT00699751 2026-02-23

ALSYMPCA

Phase 3 Completed

921 enrolled 43 charts

Hormone Refractory Prostate Cancer

NCT02141438 2025-10-16

REASSURE

1,472 enrolled 18 charts

Metastatic Castration-resistant Prostate Cancer

NCT03304418 2025-04-30

RROPE

Phase 2 Completed

20 enrolled 14 charts

Prostate Cancer Metastatic to Bone

NCT02043678 2025-02-19

ERA 223

Phase 3 Completed

806 enrolled 32 charts

Prostatic Neoplasms

NCT03002220 2024-12-11

EXCAAPE

Phase 2 Completed

52 enrolled 15 charts

Prostatic Neoplasms

NCT02903160 2024-02-07

Prostate Cancer Intensive, Non-Cross Reactive Therapy (PRINT) for Castration Resistant Prostate Cancer (CRPC)

Phase 2 Completed

40 enrolled 18 charts

Neoplasm Metastasis, Prostatic Neoplasms

NCT02258451 2023-11-24

Study of Radium-223 Dichloride in Combination With Exemestane and Everolimus Versus Placebo in Combination With Exemestane and Everolimus in Subjects With Bone Predominant HER2 Negative Hormone Receptor Positive Metastatic Breast Cancer

Phase 2 Completed

283 enrolled 22 charts

Breast Neoplasms

NCT02346526 2022-09-29

A Biomarker Study of Standard-of-care Radium-223 Chloride for Metastatic Castration-resistant Prostate Cancer

Phase 2 Completed

22 enrolled 14 charts

Prostatic Neoplasms

NCT02135484 2022-02-17

Radium 223 in Castrate Resistant Prostate Cancer Bone Metastases

Phase NA Completed

27 enrolled 9 charts

Prostatic Neoplasms

NCT02366130 2021-10-07

Trial of Ra-223 Dichloride in Combination With Hormonal Therapy and Denosumab in the Treatment of Patients With Hormone-Positive Bone-Dominant Metastatic Breast Cancer

Phase 2 Completed

45 enrolled 7 charts

Breast Neoplasms

NCT02283749 2021-02-02

BrUOG L301 With Non-Small Cell Lung Cancer and Bone Metastases

Phase 2 Completed

5 enrolled 7 charts

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT02199197 2020-10-30

Radium Ra 223 With Enzalutamide Compared to Enzalutamide Alone in Men With Metastatic Castration Refractory Prostate Cancer

Phase 2 Completed

49 enrolled 18 charts

Prostatic Neoplasms

NCT02034552 2019-07-23

A Randomized Phase IIa Efficacy and Safety Study of Radium-223 Dichloride With Abiraterone Acetate or Enzalutamide in Metastatic Castration-resistant Prostate Cancer (CRPC)

Phase 2 Completed

68 enrolled 17 charts

Prostatic Neoplasms

NCT02023697 2019-07-12

Standard Dose Versus High Dose and Versus Extended Standard Dose Radium-223 Dichloride in Castration-resistant Prostate Cancer Metastatic to the Bone

Phase 2 Completed

391 enrolled 53 charts

Prostatic Neoplasms

NCT01934790 2018-03-26

Re-treatment Safety of Radium-223 Dichloride in Castration-resistant Prostate Cancer With Bone Metastases

Phase 1/2 Completed

45 enrolled 23 charts

Prostatic Neoplasms

NCT02097303 2018-02-01

eRADicAte

Phase 2 Completed

36 enrolled 13 charts

Prostatic Neoplasms